Campylobacter fetus prosthetic hip joint infection: successful management with device retention and review.
Chambers
S T
ST
Department of Pathology, Christchurch School of Medicine, University of Otago, P.O. Box 4345, Christchurch, New Zealand. steve.chambers@cdhb.govt.nz
Morpeth
S C
SC
Laird
H M
HM
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002169:Campylobacter Infections / Q000382:microbiology* / Q000628:therapy*; D002168:Campylobacter fetus / Q000302:isolation & purification*; D002443:Ceftriaxone / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006622:Hip Prosthesis / Q000009:adverse effects*; D006801:Humans; D008297:Male; D016459:Prosthesis-Related Infections / Q000382:microbiology / Q000628:therapy*; D015575:Roxithromycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D015575:Roxithromycin; D002443:Ceftriaxone